In addition, consistent with a BRCA1-deficiency phenotype, miR-182-overexpressing breast tumor cells are hypersensitive to the inhibitors of poly (ADP-ribose) polymerase I (PARP1) [41]. Here, PARP1 is linked to breast neoplasm.